Menarini GlucoMen Areo 2K
The technology used in the Menarini GlucoMen Areo 2K, to measure blood glucose, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||★★ Recommendation||Recent clinical validation; recent protocol|
|TÜV SÜD (DE)||General use||Unpublished internal data|
|MDR Criteria||Self-measurement||Published evidence|
Dunseath GJ, Bright D, Luzio SD. Comparative Accuracy Evaluation of a Blood Glucose Meter With Novel Hematocrit Correction Technology, With Three Currently Used Commercially Available Blood Glucose Monitoring Systems. J Diabetes Sci Technol. 2019 May;13(3):568-574. Epub: 2019 Jan 9. doi: 101177/1932296818821389. PMID: 30623673. Available from: PMC6501526.
15197:2013 - Pass General population (Note: Modified protocol: Single batch of test strips only. Some hematocrit associated bias noted.)